id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0363-0046,FDA,FDA-2007-N-0363,Reference 6 Electronic Distribution of Labeling Proposed Rule Final Report,Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:25:50Z,,0,0,0900006481983f98
FDA-2007-N-0363-0044,FDA,FDA-2007-N-0363,Reference 4 Internal Analysis of Safety-Related Labeling Changes Approved by FDA Between 2003 and 2013 Source MedWatch Drug Safety Labeling Changes,Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:22:40Z,,0,0,0900006481983be8
FDA-2007-N-0363-0047,FDA,FDA-2007-N-0363,Reference 7 Electronic Distribution of Prescribing Information for Human Prescriptions Drugs Including Biological Products,Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:27:12Z,,0,0,0900006481983f99
FDA-2007-N-0363-0042,FDA,FDA-2007-N-0363,Reference 2 Electronic Drug Lageling No Consensus on the Advantages and Disadvantages of Its Exclusive Use,Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:17:51Z,,0,0,0900006481983be4
FDA-2007-N-0363-0041,FDA,FDA-2007-N-0363,Reference 1 Final Report Analysis of the Feasibility of Safety Labeling Changes Implementation Timeline,Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:15:54Z,,0,0,0900006481983be5
FDA-2007-N-0363-0040,FDA,FDA-2007-N-0363,Electronic Distribution of Prescribing Information for Human Prescription Drugs Including Biological Products,Proposed Rule,Amendment,2014-12-18T05:00:00Z,2014,12,2014-12-18T05:00:00Z,2015-03-19T03:59:59Z,2015-03-19T02:14:33Z,2014-29522,0,0,0900006481982461
FDA-2007-N-0363-0045,FDA,FDA-2007-N-0363,"Reference 5 Incidence of New Postmarket Boxed Warnings for New
Molecular Entities",Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:24:00Z,,0,0,0900006481983f97
FDA-2007-N-0363-0043,FDA,FDA-2007-N-0363,"Reference 3 Ho et al An assessment of pharmacists readiness
for paperless labeling a national survey",Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:21:00Z,,0,0,0900006481983be7
FDA-2007-N-0363-0039,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:20:02Z,,0,1,090000648197c5c5
FDA-2007-N-0363-0035,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:14:17Z,,0,1,090000648197c0fb
FDA-2007-N-0363-0037,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:16:51Z,,0,1,090000648197c5c3
FDA-2007-N-0363-0038,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:18:20Z,,0,1,090000648197c5c4
FDA-2007-N-0363-0034,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:13:28Z,,0,1,090000648197c0fa
FDA-2007-N-0363-0036,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:16:01Z,,0,1,090000648197c5c1
FDA-2007-N-0363-0033,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:11:53Z,,0,1,090000648197c0f9